180 related articles for article (PubMed ID: 36968212)
21. Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients.
Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Naruoka A; Maruyama K; Iizuka A; Ashizawa T; Mochizuki T; Urakami K; Akiyama Y; Yamaguchi K
Cancer Sci; 2020 Oct; 111(10):3893-3901. PubMed ID: 32662546
[TBL] [Abstract][Full Text] [Related]
22. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
[TBL] [Abstract][Full Text] [Related]
23. Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors.
Cristescu R; Aurora-Garg D; Albright A; Xu L; Liu XQ; Loboda A; Lang L; Jin F; Rubin EH; Snyder A; Lunceford J
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101941
[TBL] [Abstract][Full Text] [Related]
24. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.
Husain A; Chiu YT; Sze KM; Ho DW; Tsui YM; Suarez EMS; Zhang VX; Chan LK; Lee E; Lee JM; Cheung TT; Wong CC; Chung CY; Ng IO
J Hepatol; 2022 Aug; 77(2):383-396. PubMed ID: 35227773
[TBL] [Abstract][Full Text] [Related]
25. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
26. Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature.
Wen H; Guo QH; Zhou XL; Wu XH; Li J
Front Oncol; 2021; 11():792003. PubMed ID: 35071000
[TBL] [Abstract][Full Text] [Related]
27. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
28. Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Takeda M; Takahama T; Sakai K; Shimizu S; Watanabe S; Kawakami H; Tanaka K; Sato C; Hayashi H; Nonagase Y; Yonesaka K; Takegawa N; Okuno T; Yoshida T; Fumita S; Suzuki S; Haratani K; Saigoh K; Ito A; Mitsudomi T; Handa H; Fukuoka K; Nakagawa K; Nishio K
Oncologist; 2021 Apr; 26(4):e588-e596. PubMed ID: 33325566
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy.
Abou Khouzam R; Lehn JM; Mayr H; Clavien PA; Wallace MB; Ducreux M; Limani P; Chouaib S
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831579
[TBL] [Abstract][Full Text] [Related]
30. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer.
Taiakina D; Dal Pra A; Bristow RG
Adv Exp Med Biol; 2014; 772():189-204. PubMed ID: 24272360
[TBL] [Abstract][Full Text] [Related]
32. Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
Vacher S; Suybeng V; Girard E; Masliah Planchon J; Thomson G; Le Goux C; Garinet S; Schnitzler A; Chemlali W; Firlej V; Damotte D; Allory Y; Kamal M; Pignot G; Bieche I
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33049910
[TBL] [Abstract][Full Text] [Related]
33. The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.
Zhuang W; Ma J; Chen X; Wang G; Lu J; Chen Y; Dong H; Cai S; Zhang Y; Zhao X; Zhu Y; Xu C; Huang Y; Huang Z; Zhu X; Jiang H; Wang Z
J Cancer; 2018; 9(13):2302-2307. PubMed ID: 30026825
[No Abstract] [Full Text] [Related]
34. Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells.
Rodríguez-Jiménez FJ; Moreno-Manzano V; Lucas-Dominguez R; Sánchez-Puelles JM
Stem Cells; 2008 Aug; 26(8):2052-62. PubMed ID: 18511603
[TBL] [Abstract][Full Text] [Related]
35. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.
Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B
J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304
[TBL] [Abstract][Full Text] [Related]
36. SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases.
Li Y; Yang X; Zhu W; Xu Y; Ma J; He C; Wang F
Cancer Cell Int; 2022 Nov; 22(1):347. PubMed ID: 36371186
[TBL] [Abstract][Full Text] [Related]
37. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors.
Patel RR; Ramkissoon SH; Ross J; Weintraub L
Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.
Bochtler T; Wohlfromm T; Hielscher T; Stichel D; Pouyiourou M; Kraft B; Neumann O; Endris V; von Deimling A; Stenzinger A; Krämer A
Genes Chromosomes Cancer; 2022 Sep; 61(9):551-560. PubMed ID: 35430765
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.
Bristow RG; Hill RP
Nat Rev Cancer; 2008 Mar; 8(3):180-92. PubMed ID: 18273037
[TBL] [Abstract][Full Text] [Related]
40. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]